Jul 3, 2026 06:10PM
Jun 26, 2026 06:29PM
Mar 30, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 18, 2026 07:19AM
Feb 12, 2026 06:15PM
Dec 18, 2025 07:31AM Appili Therapeutics raises C$177,500 in first tranche of private placement
Dec 18, 2025 07:31AM
Nov 13, 2025 05:21PM
Nov 5, 2025 07:16AM
Nov 5, 2025 07:16AM
Oct 22, 2025 07:20AM
Oct 1, 2025 07:17AM
Oct 1, 2025 07:17AM Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01
Sep 23, 2025 05:02PM
Sep 23, 2025 05:01PM
Sep 9, 2025 07:20AM
Aug 14, 2025 05:05PM
Jun 25, 2025 06:04PM
Apr 28, 2025 07:41AM
Apr 2, 2025 08:17AM Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
Mar 18, 2025 07:22AM
Feb 14, 2025 05:06PM
Nov 14, 2024 07:15AM
Nov 7, 2024 08:30AM
Nov 6, 2024 08:30AM
Oct 31, 2024 08:30AM
Oct 28, 2024 08:15AM Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
Oct 17, 2024 07:15AM
Oct 10, 2024 08:15AM
Oct 10, 2024 07:13AM
Oct 3, 2024 08:15AM
Sep 17, 2024 05:11PM
Aug 13, 2024 05:19PM
Jul 25, 2024 08:30AM Aditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the Acquisition
Jun 25, 2024 05:46PM
Apr 2, 2024 08:30AM
Apr 2, 2024 08:30AM
Mar 12, 2024 07:12AM
Dec 15, 2023 07:27AM
Nov 13, 2023 04:24PM
Oct 25, 2023 07:49AM Appili Therapeutics’ Biodefense Vaccine Candidate ATI-1701 is Awarded Additional Funding from the U.S. Air Force Academy
Sep 27, 2023 07:21PM
Sep 25, 2023 07:54AM
Aug 11, 2023 04:50PM
Jun 23, 2023 05:07PM
Jun 23, 2023 07:21AM
May 24, 2023 07:19AM
May 8, 2023 07:38AM Appili Therapeutics Secures Contract for ATI-1701 Funding from the U.S. Air Force Academy
Apr 18, 2023 07:17AM

325,998 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All